MPM
MBB Public Markets’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-209,271
| Closed | -$20.7M | – | 526 |
|
2024
Q3 | $20.7M | Sell |
209,271
-36,348
| -15% | -$3.59M | 1.16% | 17 |
|
2024
Q2 | $22.8M | Sell |
245,619
-47,279
| -16% | -$4.38M | 0.46% | 40 |
|
2024
Q1 | $27.8M | Sell |
292,898
-351,580
| -55% | -$33.4M | 1.7% | 18 |
|
2023
Q4 | $57.5M | Buy |
644,478
+130,067
| +25% | +$11.6M | 3.54% | 9 |
|
2023
Q3 | $37.6M | Buy |
514,411
+206,337
| +67% | +$15.1M | 2.27% | 10 |
|
2023
Q2 | $25.6M | Sell |
308,074
-198,106
| -39% | -$16.5M | 1.34% | 20 |
|
2023
Q1 | $38.6M | Sell |
506,180
-19,242
| -4% | -$1.47M | 2.14% | 11 |
|
2022
Q4 | $43.6M | Buy |
525,422
+35,000
| +7% | +$2.91M | 1.18% | 11 |
|
2022
Q3 | $38.9M | Sell |
490,422
-348,427
| -42% | -$27.6M | 1.02% | 10 |
|
2022
Q2 | $62.3M | Buy |
838,849
+351,643
| +72% | +$26.1M | 1.47% | 6 |
|
2022
Q1 | $43.8M | Buy |
487,206
+458,192
| +1,579% | +$41.2M | 0.9% | 8 |
|
2021
Q4 | $3.25M | Buy |
+29,014
| New | +$3.25M | 0.06% | 41 |
|